Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke
Objective
Stroke is a devastating and costly disease; however, there is a paucity of information on long-term costs and on how they differ according to 3-month modified Rankin scale (mRS) score, which is a primary outcome variable in acute stroke intervention trials.
Methods
We analyzed a prospective multicenter stroke registry (Clinical Research Collaboration for Stroke in Korea) database through linkage with claims data from the National Health Insurance Service with follow-up to December 2016. Healthcare expenditures were converted into daily cost individually, and annual and cumulative costs up to 5 years were estimated and compared according to the 3-month mRS score.
Results
Between January 2011 and November 2013, 11,136 patients were enrolled in the study. The mean age was 68 years, and 58% were men. The median follow-up period was 3.9 years (range 0–5 years). Mean cumulative cost over 5 years was $117,576 (US dollars [USD]); the cost in the first year after stroke was the highest ($38,152 USD), which increased markedly from the cost a year before stroke ($8,718 USD). The mean 5-year cumulative costs differed significantly according to the 3-month mRS score (p < 0.001); the costs for a 3-month mRS score of 0 or 5 were $53,578 and $257,486 USD, respectively. Three-month mRS score was an independent determinant of long-term costs after stroke.
Conclusions
We show that 3-month mRS score plays an important role in the prediction of long-term costs after stroke. Such estimates relating to 3-month mRS categories may be valuable when undertaking health economic evaluations related to stroke care.
Top-30
Journals
|
1
2
3
4
|
|
|
Neurology
4 publications, 16.67%
|
|
|
Stroke
3 publications, 12.5%
|
|
|
Frontiers in Neurology
1 publication, 4.17%
|
|
|
Journal of Stroke
1 publication, 4.17%
|
|
|
BMC Health Services Research
1 publication, 4.17%
|
|
|
Acta Neurologica Belgica
1 publication, 4.17%
|
|
|
PharmacoEconomics & Outcomes News
1 publication, 4.17%
|
|
|
Scientific Reports
1 publication, 4.17%
|
|
|
Journal of Telemedicine and Telecare
1 publication, 4.17%
|
|
|
Journal of Vascular Surgery
1 publication, 4.17%
|
|
|
EClinicalMedicine
1 publication, 4.17%
|
|
|
Archives of Physical Medicine and Rehabilitation
1 publication, 4.17%
|
|
|
British Journal of Nutrition
1 publication, 4.17%
|
|
|
Journal of NeuroInterventional Surgery
1 publication, 4.17%
|
|
|
JAMA Neurology
1 publication, 4.17%
|
|
|
Circulation: Cardiovascular Quality and Outcomes
1 publication, 4.17%
|
|
|
Stroke and Vascular Neurology
1 publication, 4.17%
|
|
|
Value in Health
1 publication, 4.17%
|
|
|
Journal of Korean Medical Science
1 publication, 4.17%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Ovid Technologies (Wolters Kluwer Health)
8 publications, 33.33%
|
|
|
Springer Nature
4 publications, 16.67%
|
|
|
Elsevier
4 publications, 16.67%
|
|
|
BMJ
2 publications, 8.33%
|
|
|
Frontiers Media S.A.
1 publication, 4.17%
|
|
|
Korean Stroke Society
1 publication, 4.17%
|
|
|
SAGE
1 publication, 4.17%
|
|
|
Cambridge University Press
1 publication, 4.17%
|
|
|
American Medical Association (AMA)
1 publication, 4.17%
|
|
|
Korean Academy of Medical Sciences
1 publication, 4.17%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.